LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Momelotinib | 0.04 | uM | LJP5 | 1 | P12 | 72 | hr | 2543 | 5395 | 5734 | 0.9408 | 0.8986 |
| SK-BR-3 | Momelotinib | 0.04 | uM | LJP5 | 2 | P12 | 72 | hr | 2543 | 4917 | 5761 | 0.8534 | 0.7486 |
| SK-BR-3 | Momelotinib | 0.04 | uM | LJP5 | 3 | P12 | 72 | hr | 2543 | 5596 | 5760 | 0.9714 | 0.9514 |
| SK-BR-3 | Momelotinib | 0.12 | uM | LJP5 | 1 | P11 | 72 | hr | 2543 | 4727 | 5734 | 0.8243 | 0.6962 |
| SK-BR-3 | Momelotinib | 0.12 | uM | LJP5 | 2 | P11 | 72 | hr | 2543 | 5059 | 5761 | 0.8781 | 0.7913 |
| SK-BR-3 | Momelotinib | 0.12 | uM | LJP5 | 3 | P11 | 72 | hr | 2543 | 5191 | 5760 | 0.9011 | 0.8310 |
| SK-BR-3 | Momelotinib | 0.37 | uM | LJP5 | 1 | P10 | 72 | hr | 2543 | 4997 | 5734 | 0.8714 | 0.7785 |
| SK-BR-3 | Momelotinib | 0.37 | uM | LJP5 | 2 | P10 | 72 | hr | 2543 | 5025 | 5761 | 0.8722 | 0.7811 |
| SK-BR-3 | Momelotinib | 0.37 | uM | LJP5 | 3 | P10 | 72 | hr | 2543 | 5068 | 5760 | 0.8797 | 0.7941 |
| SK-BR-3 | Momelotinib | 1.11 | uM | LJP5 | 1 | P09 | 72 | hr | 2543 | 4597 | 5734 | 0.8016 | 0.6564 |
| SK-BR-3 | Momelotinib | 1.11 | uM | LJP5 | 2 | P09 | 72 | hr | 2543 | 4701 | 5761 | 0.8159 | 0.6832 |
| SK-BR-3 | Momelotinib | 1.11 | uM | LJP5 | 3 | P09 | 72 | hr | 2543 | 5198 | 5760 | 0.9023 | 0.8331 |
| SK-BR-3 | Momelotinib | 3.33 | uM | LJP5 | 1 | P08 | 72 | hr | 2543 | 4174 | 5734 | 0.7279 | 0.5255 |
| SK-BR-3 | Momelotinib | 3.33 | uM | LJP5 | 2 | P08 | 72 | hr | 2543 | 4460 | 5761 | 0.7741 | 0.6098 |
| SK-BR-3 | Momelotinib | 3.33 | uM | LJP5 | 3 | P08 | 72 | hr | 2543 | 4385 | 5760 | 0.7612 | 0.5869 |
| SK-BR-3 | Momelotinib | 10 | uM | LJP5 | 1 | P07 | 72 | hr | 2543 | 2610 | 5734 | 0.4551 | 0.0223 |
| SK-BR-3 | Momelotinib | 10 | uM | LJP5 | 2 | P07 | 72 | hr | 2543 | 2712 | 5761 | 0.4707 | 0.0559 |
| SK-BR-3 | Momelotinib | 10 | uM | LJP5 | 3 | P07 | 72 | hr | 2543 | 3015 | 5760 | 0.5234 | 0.1551 |
| SK-BR-3 | Fedratinib | 0.04 | uM | LJP5 | 1 | L06 | 72 | hr | 2543 | 5792 | 5734 | 1.0100 | 1.0171 |
| SK-BR-3 | Fedratinib | 0.04 | uM | LJP5 | 2 | L06 | 72 | hr | 2543 | 5558 | 5761 | 0.9647 | 0.9400 |
| SK-BR-3 | Fedratinib | 0.04 | uM | LJP5 | 3 | L06 | 72 | hr | 2543 | 5780 | 5760 | 1.0033 | 1.0056 |
| SK-BR-3 | Fedratinib | 0.12 | uM | LJP5 | 1 | L05 | 72 | hr | 2543 | 5741 | 5734 | 1.0011 | 1.0019 |
| SK-BR-3 | Fedratinib | 0.12 | uM | LJP5 | 2 | L05 | 72 | hr | 2543 | 5422 | 5761 | 0.9411 | 0.8997 |
| SK-BR-3 | Fedratinib | 0.12 | uM | LJP5 | 3 | L05 | 72 | hr | 2543 | 5952 | 5760 | 1.0332 | 1.0561 |
| SK-BR-3 | Fedratinib | 0.37 | uM | LJP5 | 1 | L04 | 72 | hr | 2543 | 5440 | 5734 | 0.9486 | 0.9121 |